Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials
Summary: With coronavirus inhibiting the traditional approach to clinical trials, many companies are adopting the decentralized trial approach. Decentralized trials were on-the-rise even before the pandemic, boasting higher recruitment and retention rates for patients who prefer trials without the logistical challenges of in-clinic attendance.